L-asparaginase: New about Well-Known Drug
The history of asparaginase clinical use is inextricably linked to the improvement of treatment programs for acute lymphoblastic leukaemia (ALL). Asparaginase, obtained from E. coli, has become the crucial part in the protocols for the treatment of ALL in children and adults since the 1960s-1970s du...
Saved in:
| Main Authors: | Yuliya S. Korkina, Timur T. Valiev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2021-07-01
|
| Series: | Педиатрическая фармакология |
| Subjects: | |
| Online Access: | https://www.pedpharma.ru/jour/article/view/2017 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toxicity of L-asparaginase drugs in acute lymphoblastic leukemia treatment
by: T. T. Valiev
Published: (2023-09-01) -
Successful treatment of pancreatitis caused by L-asparaginase in clinical practice
by: Yu. S. Korkina, et al.
Published: (2024-01-01) -
Affordable and safe health care for all children: Lessons learned from the use of peg-asparaginase in a developing country
by: Dhaarani Jayaraman, et al.
Published: (2017-01-01) -
Screening of Bacteria Producing Asparaginase Free of Glutaminase and Urease from Hot Springs in West Sulawesi
by: Ruby Setiawan, et al.
Published: (2019-08-01) -
Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance
by: Shih-Hsiang Chen
Published: (2015-10-01)